Datasets for next-generation sequencing of DNA and RNA from urine and plasma of patients with prostate cancer

Current prostate cancer (PCa) diagnostic tests suffer from insufficient sensitivity and specificity. Novel biomarkers that can be detected by minimally invasive methods are of a particular value. Here we provide two datasets. The first one is on the whole transcriptome profiling by RNA-seq of urine...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikitina, A.S., Sharova, E.I., Danilenko, S.A., Selezneva, O.V., Butusova, T.B., Vasiliev, A.O., Govorov, A.V., Prilepskaya, E.A., Pushkar, D.Y., Kostryukova, E.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Data Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175992/
https://www.ncbi.nlm.nih.gov/pubmed/28018951
http://dx.doi.org/10.1016/j.dib.2016.12.016
Descripción
Sumario:Current prostate cancer (PCa) diagnostic tests suffer from insufficient sensitivity and specificity. Novel biomarkers that can be detected by minimally invasive methods are of a particular value. Here we provide two datasets. The first one is on the whole transcriptome profiling by RNA-seq of urine and plasma obtained from patients with PCa and benign prostatic hyperplasia (BPH). The second one represents targeted sequencing of DNA from urine and plasma of patients with PCa and BPH. Both datasets are available at NCBI Sequence Read Archive under Accession No. SRP093707 and No. SRP093842 respectively.

Ejemplares similares